All of the latest trial updates are listed for presentation at...

All of the latest trial updates are listed for presentation at ESMO 2016  in October.

9th Oct
1157TiP - Phase Ib study of intratumoral oncolytic coxsackievirus A21 (CVA21) and pembrolizumab in subjects with advanced melanoma

1104TiP - Intravenous coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients: Phase Ib KEYNOTE 200 study

10th Oct
1051PD - The MITCI (phase 1b) study: A novel immunotherapy combination of coxsackievirus A21 and ipilimumab in patients with advanced melanoma

1054PD - Phase I/II CANON study: Oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21


It should be a very exciting time.   Only 2 more months to wait .....

https://cslide.ctimeetingtech.com/library/esmo/browse/itinerary/5286/2016-10-09#2z95v
https://cslide.ctimeetingtech.com/library/esmo/browse/itinerary/5286/2016-10-10#2z952

.